APOLIPOPROTEIN E4 PROMOTES INCIPIENT ALZHEIMER PATHOLOGY IN THE ELDERLY

Citation
Rw. Warzok et al., APOLIPOPROTEIN E4 PROMOTES INCIPIENT ALZHEIMER PATHOLOGY IN THE ELDERLY, Alzheimer disease and associated disorders, 12(1), 1998, pp. 33-39
Citations number
47
Categorie Soggetti
Clinical Neurology",Pathology
ISSN journal
08930341
Volume
12
Issue
1
Year of publication
1998
Pages
33 - 39
Database
ISI
SICI code
0893-0341(1998)12:1<33:AEPIAP>2.0.ZU;2-K
Abstract
To evaluate the influence of the apolipoprotein E (ApoE) epsilon 4 all ele on the age at which Alzheimer-like lesions appear in the brain, we analyzed the degree of cerebral beta-amyloidosis and neurofibrillary tangle formation in the hippocampal formation and adjacent cortical ar eas 28, 27, and 36 of persons who had died between the ages of 50 and 93 years and who had shown no signs of clinical dementia. The occurren ce of the three common polymorphisms of the ApoE gene in this sample o f 147 routine autopsy cases from eastern Germany was comparable to pre viously reported values in European and North American populations: Ap oE epsilon 2/2, 0.7%; ApoE epsilon 2/3, 14.3%; ApoE epsilon 2/4, 4.1%; ApoE epsilon 3/3, 56.5%; ApoE epsilon 3/4, 22.4%; and ApoE epsilon 4/ 4, 2.0%. Nondemented persons carrying the ApoE epsilon 4 allele were s ignificantly more likely to have senile plaques, diffuse amyloid depos its, cerebrovascular amyloid and neurofibrillary tangles than were tho se lacking epsilon 4. Comparing the two largest ApoE subgroups, ApoE e psilon 3/3 and ApoE epsilon 3/4, the relative increase in the occurren ce of beta-amyloid in the epsilon 3/4 group was evident by the mid-60s , with the relative increase in neurofibrillary tangles in this group emerging slightly earlier. The ApoE epsilon 2 allele appears to delay the appearance of the lesions somewhat. We conclude that ApoE epsilon 4, promotes the early appearance of beta-amyloid and neurofibrillary t angles in the elderly and that the increased frequency of these lesion s is related to the higher risk of Alzheimer disease in persons bearin g the ApoE epsilon 3 allele.